The discovery of activating TERT promoter mutations across multiple human cancer histotypes [10] and the identification of numerous cancer susceptibility loci within non‐coding regions through genome‐wide association studies (GWAS) [11, 12] have highlighted the potential of non‐coding variants as significant drivers of tumorigenesis. Here, TERT is linked to cancer.